Search

Your search keyword '"Chertow G.M."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Chertow G.M." Remove constraint Author: "Chertow G.M."
31 results on '"Chertow G.M."'

Search Results

3. POS-255 EFFECT OF DAPAGLIFLOZIN ON BLOOD PRESSURE IN PATIENTS WITH CKD: A PRE-SPECIFIED ANALYSIS FROM DAPA-CKD

4. POS-202 DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE TREATED WITH MINERALOCORTICOID RECEPTOR ANTAGONISTS: PRE-SPECIFIED ANALYSIS OF THE DAPA-CKD TRIAL

10. POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE DAPA-CKD TRIAL

11. POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

13. Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial

15. Conference Participants. Iron management in chronic kidney disease: conclusions from a 'Kidney Disease: Improving Global Outcomes' (KDIGO) Controversies Conference

19. The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review.

26. The Effects of Sevelamer and Calcium Acetate on Proxies of Atherosclerotic and Arteriosclerotic Vascular Disease in Hemodialysis Patients

27. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

29. Sevelamer, Ca×P product and vitamin D

30. Outcome Poor for ESRD Patients Treated Only with Drugs after Heart Attack.

31. Health status after invasive or conservative care in coronary and advanced kidney disease

Catalog

Books, media, physical & digital resources